Arbutus Biopharma Corp Quarterly Operating Margin in % from Q4 2013 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Arbutus Biopharma Corp quarterly/annual Operating Margin history and growth rate from Q4 2013 to Q3 2024.
  • Arbutus Biopharma Corp Operating Margin for the quarter ending September 30, 2024 was -1.23K %, a 243% decline year-over-year.
  • Arbutus Biopharma Corp annual Operating Margin for 2023 was -431 %, a 157% decline from 2022.
  • Arbutus Biopharma Corp annual Operating Margin for 2022 was -168 %, a 74.9% increase from 2021.
  • Arbutus Biopharma Corp annual Operating Margin for 2021 was -669 %, a 20% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -1.23K -874 -243% Jul 1, 2024 Sep 30, 2024
Q2 2024 -827 -504 -156% Apr 1, 2024 Jun 30, 2024
Q1 2024 -616 -399 -184% Jan 1, 2024 Mar 31, 2024
Q4 2023 -431 -263 -157% Oct 1, 2023 Dec 31, 2023
Q3 2023 -359 -182 -103% Jul 1, 2023 Sep 30, 2023
Q2 2023 -324 -131 -68% Apr 1, 2023 Jun 30, 2023
Q1 2023 -217 +104 +32.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -168 +501 +74.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 -177 +502 +73.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -193 +596 +75.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -321 +480 +59.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -669 +167 +20% Oct 1, 2021 Dec 31, 2021
Q3 2021 -679 +209 +23.6% Jul 1, 2021 Sep 30, 2021
Q2 2021 -788 +909 +53.5% Apr 1, 2021 Jun 30, 2021
Q1 2021 -801 +1.22K +60.4% Jan 1, 2021 Mar 31, 2021
Q4 2020 -836 +1.56K +65.1% Oct 1, 2020 Dec 31, 2020
Q3 2020 -888 +1.55K +63.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 -1.7K +243 +12.5% Apr 1, 2020 Jun 30, 2020
Q1 2020 -2.02K -275 -15.8% Jan 1, 2020 Mar 31, 2020
Q4 2019 -2.39K -885 -58.6% Oct 1, 2019 Dec 31, 2019
Q3 2019 -2.43K -477 -24.3% Jul 1, 2019 Sep 30, 2019
Q2 2019 -1.94K -1K -107% Apr 1, 2019 Jun 30, 2019
Q1 2019 -1.75K -813 -87.1% Jan 1, 2019 Mar 31, 2019
Q4 2018 -1.51K -473 -45.7% Oct 1, 2018 Dec 31, 2018
Q3 2018 -1.96K +1.91K +49.4% Jul 1, 2018 Sep 30, 2018
Q2 2018 -938 +16K +94.5% Apr 1, 2018 Jun 30, 2018
Q1 2018 -933 +42.7K +97.9% Jan 1, 2018 Mar 31, 2018
Q4 2017 -1.04K +31.9K +96.9% Oct 1, 2017 Dec 31, 2017
Q3 2017 -3.87K -2.15K -126% Jul 1, 2017 Sep 30, 2017
Q2 2017 -17K -15.3K -950% Apr 1, 2017 Jun 30, 2017
Q1 2017 -43.6K -43.1K -8599% Jan 1, 2017 Mar 31, 2017
Q4 2016 -33K -32.6K -7915% Oct 1, 2016 Dec 31, 2016
Q3 2016 -1.71K -1.1K -179% Jul 1, 2016 Sep 30, 2016
Q2 2016 -1.61K -1.32K -443% Apr 1, 2016 Jun 30, 2016
Q1 2016 -502 -205 -69.4% Jan 1, 2016 Mar 31, 2016
Q4 2015 -411 -191 -86.6% Oct 1, 2015 Dec 31, 2015
Q3 2015 -613 -395 -182% Jul 1, 2015 Sep 30, 2015
Q2 2015 -297 -81.5 -37.8% Apr 1, 2015 Jun 30, 2015
Q1 2015 -296 -159 -115% Jan 1, 2015 Mar 31, 2015
Q4 2014 -221 -80.7 -57.7% Oct 1, 2014 Dec 31, 2014
Q3 2014 -217 Jul 1, 2014 Sep 30, 2014
Q2 2014 -216 Apr 1, 2014 Jun 30, 2014
Q1 2014 -138 Jan 1, 2014 Mar 31, 2014
Q4 2013 -140 Oct 1, 2013 Dec 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.